CDSCO

Takeda's recombinant live attenuated tetravalent dengue vaccine receives marketing authorisation for dengue prevention in India

The India-UK Comprehensive Economic and Trade Agreement (CETA), which came into force on July 15, is expected to create fresh…

Breast cancer remains one of the most prevalent cancers worldwide, accounting for 11.7 per cent of all cancer cases. In India, it…

The Central Drugs Standard Control Organization (CDSCO) has released a draft guidance document on the conduct and regulation of…

The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare…

Dr Jay Goyal, Eye Surgeon, LASIK specialist, Retina Specialist, and Director, Surya Eye Hospital, sheds light on India’s…

The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related…

Industry experts from India’s medical devices sector have responded with a mix of optimism and caution to the recently announced…

State FDA, Karnataka, clears Medios HI Glaucoma AI and Medios HI AMD AI for nationwide use, expanding access to early detection…

SS Innovations International reported revenues reaching $20.6 million for the year ending December 31, 2024, rising by 40.9 % from…